Global Market Direct’s pharmaceuticals report, “Thrasos, Inc. - Product Pipeline Review - 2013” provides data on the Thrasos, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Thrasos, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Thrasos, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.
- Thrasos, Inc. - Brief Thrasos, Inc. overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of Thrasos, Inc. human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of Thrasos, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the Thrasos, Inc.’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products.
Reasons to buy
- Evaluate Thrasos, Inc.’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of Thrasos, Inc. in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the Thrasos, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with Thrasos, Inc.. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of Thrasos, Inc. and identify potential opportunities in those areas.
Table Of Contents
Thrasos, Inc. - Product Pipeline Review - 2013 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 3 Thrasos, Inc. Snapshot 4 Thrasos, Inc. Overview 4 Key Information 4 Key Facts 4 Thrasos, Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 Thrasos, Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Thrasos, Inc. - Pipeline Products Glance 9 Thrasos, Inc. Clinical Stage Pipeline Products 9 Phase II Products/Combination Treatment Modalities 9 Thrasos, Inc. - Early Stage Pipeline Products 10 Preclinical Products/Combination Treatment Modalities 10 Discovery Products/Combination Treatment Modalities 11 Thrasos, Inc. - Drug Profiles 12 Drug For Obesity 12 Product Description 12 Mechanism of Action 12 RandD Progress 12 Drug For Prostate and Breast Cancer 13 Product Description 13 Mechanism of Action 13 RandD Progress 13 THR-123 14 Product Description 14 Mechanism of Action 14 RandD Progress 14 THR-166 15 Product Description 15 Mechanism of Action 15 RandD Progress 15 THR-184 16 Product Description 16 Mechanism of Action 16 RandD Progress 16 Thrasos, Inc. - Pipeline Analysis 17 Thrasos, Inc. - Pipeline Products by Therapeutic Class 17 Thrasos, Inc. - Pipeline Products By Target 19 Thrasos, Inc. - Pipeline Products by Route of Administration 20 Thrasos, Inc. - Pipeline Products By Mechanism of Action 21 Thrasos, Inc. - Recent Pipeline Updates 22 Thrasos, Inc. - Dormant Projects 23 Thrasos, Inc. - Locations And Subsidiaries 24 Head Office 24 Appendix 25 Methodology 25 Coverage 25 Secondary Research 25 Primary Research 25 Expert Panel Validation 25 Contact Us 26 Disclaimer 26
List of Tables
Thrasos, Inc., Key Information 4 Thrasos, Inc., Key Facts 4 Thrasos, Inc. - Pipeline by Indication, 2013 6 Thrasos, Inc. - Pipeline by Stage of Development, 2013 7 Thrasos, Inc. - Monotherapy Products in Pipeline, 2013 8 Thrasos, Inc. - Phase II, 2013 9 Thrasos, Inc. - Preclinical, 2013 10 Thrasos, Inc. - Discovery, 2013 11 Thrasos, Inc. - Pipeline By Therapeutic Class, 2013 18 Thrasos, Inc. - Pipeline By Target, 2013 19 Thrasos, Inc. - Pipeline By Route of Administration, 2013 20 Thrasos, Inc. - Pipeline Products By Mechanism of Action, 2013 21 Thrasos, Inc. - Recent Pipeline Updates, 2013 22 Thrasos, Inc. - Dormant Developmental Projects,2013 23
List of Figures
Thrasos, Inc. - Pipeline by Indication, 2013 6 Thrasos, Inc. - Pipeline by Stage of Development, 2013 7 Thrasos, Inc. - Monotherapy Products in Pipeline, 2013 8 Thrasos, Inc. - Pipeline By Therapeutic Class, 2013 17 Thrasos, Inc. - Pipeline By Route of Administration, 2013 20 Thrasos, Inc. - Pipeline Products By Mechanism of Action, 2013 21